Back to Journals » Journal of Inflammation Research » Volume 18
RETRACTED ARTICLE: IFN-γ Induces Pleural Mesothelial Cells to Recruit Immune Cells via CXCL10-CXCR3 Axis in a Mouse Pleurisy Model
Authors Dong SF, Shi X, Wu X, Yi FS
Received 1 November 2024
Accepted for publication 30 January 2025
Published 20 February 2025 Volume 2025:18 Pages 2521—2530
DOI https://doi.org/10.2147/JIR.S496037
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Tara Strutt
This paper has been retracted.
Dong SF, Shi X, Wu X, Yi FS. J Inflamm Res. 2025;18:2521–2530.
We, the authors, Editors and Publisher of the Journal of Inflammation Research, have retracted the published article.
Since publication, the authors contacted the journal to notify the Editors that the experiments related to isolation and purification of pleural mesothelial cells from mice were conducted prior to obtaining ethical approval and requested the retraction of their article.
As this constitutes a violation of Dove Medical Press editorial policies and established ethical research standards, upon the authors’ disclosure of this matter to the Editor and Publisher, a joint decision has been made to retract this article.
We have been informed in our decision-making by our Editorial policies and the COPE guidelines. The authors agree with the retraction.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.
© 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.